Chemours (CC) Tops Q4 EPS by 22c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
The Chemours Company Reports Fourth Quarter and Full Year 2017 Results; Robust Performance Across All Segments and Key Financial Metrics
February 14, 2018 4:15 PM EST
WILMINGTON, Del., Feb. 14, 2018 /PRNewswire/ --
Fourth Quarter 2017 Highlights
Net Sales of $1.6 billion, up 19% Net Income of $228 million, up $458 million with EPS of $1.19 per diluted share, up $2.45 per diluted share Adjusted Net Income of $229 million, up $196 million with Adjusted EPS of $1.19 per diluted share, up $1.01 per diluted share Adjusted EBITDA of $394 million, up 65%Full Year 2017 Highlights
Net Sales of $6.2 billion, up 15% Net Income of $746 million, up $739 million with EPS of $3.91 per diluted share, up $3.87 per diluted share Adjusted... More